Randall Mack
Keine laufenden Positionen mehr
Profil
Randall Mack worked as Vice President of Project Management & Operations at Adolor Corp.
and Vice President of Clinical Development at Auxilium Pharmaceuticals LLC.
He also served as Executive Vice President of Development at Societal CDMO, Inc. from 2008 to 2013.
Mr. Mack obtained an undergraduate degree from The University of Nebraska-Lincoln.
Ehemalige bekannte Positionen von Randall Mack
| Unternehmen | Position | Ende |
|---|---|---|
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Corporate Officer/Principal | - |
| AUXILIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| SOCIETAL CDMO, INC. | Corporate Officer/Principal | 25.10.2013 |
Ausbildung von Randall Mack
| The University of Nebraska-Lincoln | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SOCIETAL CDMO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |